Ronald Silver - Jul 19, 2021 Form 3 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)

Role
Principal Accounting Officer
Signature
/s/ Brian Tessler, Attorney-in-Fact
Stock symbol
IRWD
Transactions as of
Jul 19, 2021
Transactions value $
$0
Form type
3
Date filed
7/22/2021, 04:13 PM
Next filing
Jul 22, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding IRWD Class A Common Stock 43.2K Jul 19, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IRWD Employee Stock Option (Right to Buy) Jul 19, 2021 Class A Common Stock 9.66K $17.37 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option, granted as a new hire award, vested as to 25% of the shares of Class A Common Stock on June 4, 2019, and 2.08333% of the shares of Class A Common Stock vest each month thereafter for the next 36 months.

Remarks:

Exhibit 24: Power of Attorney